CIK: 1611193 - Address: C/o Ardelyx, Inc., 34175 Ardenwood Blvd, Suite 200, Fremont, CA 94555
32 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
S%ret1111-1-1-5-24-34-35-17
S%wins555573707810072

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
11/24/21 16:06
11/22/21
ARDXArdelyx, Inc.DEHealthDrugPharmaceutical PreparationsJacobs Jeffrey WCAOChief ScS-60.97830-6-5119D
11/16/21 17:54
11/15/21
ARDXArdelyx, Inc.DEHealthDrugPharmaceutical PreparationsJacobs Jeffrey WCAOChief ScS-61.130-5-4125D
11/10/21 17:17
11/8/21
ARDXArdelyx, Inc.DEHealthDrugPharmaceutical PreparationsJacobs Jeffrey WCAOChief ScS-31.180-2-2130D
8/24/21 18:06
8/20/21
ARDXArdelyx, Inc.DEHealthDrugPharmaceutical PreparationsJacobs Jeffrey WCAOChief ScS-11.320-1-1128D
8/5/21 17:00
8/3/21
ARDXArdelyx, Inc.DEHealthDrugPharmaceutical PreparationsJacobs Jeffrey WCAOChief ScM.d50.54000108128D
6/17/21 16:32
6/15/21
ARDXArdelyx, Inc.DEHealthDrugPharmaceutical PreparationsJacobs Jeffrey WCAOChief ScM.d40.5400086124D
6/17/21 16:32
6/15/21
ARDXArdelyx, Inc.DEHealthDrugPharmaceutical PreparationsJacobs Jeffrey WCAOChief ScS.d-557.290-8-6124D
5/21/21 16:47
5/20/21
ARDXArdelyx, Inc.DEHealthDrugPharmaceutical PreparationsJacobs Jeffrey WCAOChief ScS-57.090-1-1124D
2/24/21 16:41
2/22/21
ARDXArdelyx, Inc.DEHealthDrugPharmaceutical PreparationsJacobs Jeffrey WCAOChief ScS-56.880-1-1125D
12/22/20 16:10
12/21/20
ARDXArdelyx, Inc.DEHealthDrugPharmaceutical PreparationsJacobs Jeffrey WCAOChief ScS-276.880-4-493D
9/17/20 18:30
9/15/20
ARDXArdelyx, Inc.DEHealthDrugPharmaceutical PreparationsJacobs Jeffrey WCAOSVP,TechS.m-2865.630-51-3497D
3/3/17 19:39
3/1/17
ARDXArdelyx, Inc.DEHealthDrugPharmaceutical PreparationsJacobs Jeffrey WCAOSVP,TechM.d20.540043568D-83434-11123102-3-5-11
3/3/17 19:39
3/1/17
ARDXArdelyx, Inc.DEHealthDrugPharmaceutical PreparationsJacobs Jeffrey WCAOSVP,TechS.d-4113.704-3-468D-83434-11123102-3-5-11
2/3/17 19:09
2/1/17
ARDXArdelyx, Inc.DEHealthDrugPharmaceutical PreparationsJacobs Jeffrey WCAOSVP,TechM.d20.540033568D-28137-12-22-19-12-4-132414
2/3/17 19:09
2/1/17
ARDXArdelyx, Inc.DEHealthDrugPharmaceutical PreparationsJacobs Jeffrey WCAOSVP,TechS.d-3612.003-3-468D-28137-12-22-19-12-4-132414
10/13/16 19:39
10/11/16
ARDXArdelyx, Inc.DEHealthDrugPharmaceutical PreparationsJacobs Jeffrey WCAOSVP,TechM.d30.5400361450D-32-326657381662-6-262-12
10/13/16 19:39
10/11/16
ARDXArdelyx, Inc.DEHealthDrugPharmaceutical PreparationsJacobs Jeffrey WCAOSVP,TechS.d-9015.003-6-1150D-32-326657381662-6-262-12
12/17/15 17:12
12/15/15
ARDXArdelyx, Inc.DEHealthDrugPharmaceutical PreparationsJacobs Jeffrey WCAOSVP,TechM.d10.540022447D-1422-71021181-3-44-62-57-24
12/17/15 17:12
12/15/15
ARDXArdelyx, Inc.DEHealthDrugPharmaceutical PreparationsJacobs Jeffrey WCAOSVP,TechS.d-4020.002-2-447D-1422-71021181-3-44-62-57-24
12/1/15 17:21
11/27/15
ARDXArdelyx, Inc.DEHealthDrugPharmaceutical PreparationsJacobs Jeffrey WCAOSVP,TechM.d10.540022447D-2783322961-12-5-50-57-23
12/1/15 17:21
11/27/15
ARDXArdelyx, Inc.DEHealthDrugPharmaceutical PreparationsJacobs Jeffrey WCAOSVP,TechS.d-4020.002-2-447D-2783322961-12-5-50-57-23
10/13/15 17:01
10/8/15
ARDXArdelyx, Inc.DEHealthDrugPharmaceutical PreparationsJacobs Jeffrey WCAOSVP,TechM.d10.540032447D557168-4222-7-4-4-47-59-25
10/13/15 17:01
10/8/15
ARDXArdelyx, Inc.DEHealthDrugPharmaceutical PreparationsJacobs Jeffrey WCAOSVP,TechS.d-4019.883-2-447D557168-4222-7-4-4-47-59-25
9/11/15 19:53
9/10/15
ARDXArdelyx, Inc.DEHealthDrugPharmaceutical PreparationsJacobs Jeffrey WCAOSVP,TechM.d10.540032447D5033419199923-1-15-61-50
9/11/15 19:53
9/10/15
ARDXArdelyx, Inc.DEHealthDrugPharmaceutical PreparationsJacobs Jeffrey WCAOSVP,TechS.d-4120.593-2-447D5033419199923-1-15-61-50
8/11/15 15:56
8/6/15
ARDXArdelyx, Inc.DEHealthDrugPharmaceutical PreparationsJacobs Jeffrey WCAOSVP,TechM.d10.540032447D5514101213-4-634106-49-44
8/11/15 15:56
8/6/15
ARDXArdelyx, Inc.DEHealthDrugPharmaceutical PreparationsJacobs Jeffrey WCAOSVP,TechS.d-3819.073-2-447D5514101213-4-634106-49-44
7/29/15 17:28
7/28/15
ARDXArdelyx, Inc.DEHealthDrugPharmaceutical PreparationsJacobs Jeffrey WCAOSVP,TechM.d10.540023647D28-24702523168-23-8-11-45-43
7/29/15 17:28
7/28/15
ARDXArdelyx, Inc.DEHealthDrugPharmaceutical PreparationsJacobs Jeffrey WCAOSVP,TechS.d-5020.002-3-547D28-24702523168-23-8-11-45-43
3/4/15 19:11
3/2/15
ARDXArdelyx, Inc.DEHealthDrugPharmaceutical PreparationsJacobs Jeffrey WCAOVP,ChemiS-1615.812-1-247D3-42-39-2-10-43-2-15-3222-33
2/6/15 18:40
2/4/15
ARDXArdelyx, Inc.DEHealthDrugPharmaceutical PreparationsJacobs Jeffrey WCAOVP,ChemiM.d101.08492447D29-29-30-34-38-1703-5-4616-38
2/6/15 18:40
2/4/15
ARDXArdelyx, Inc.DEHealthDrugPharmaceutical PreparationsJacobs Jeffrey WCAOVP,ChemiS.d-14516.284-9-1647D29-29-30-34-38-1703-5-4616-38

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact